Cargando…
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of g...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382400/ https://www.ncbi.nlm.nih.gov/pubmed/30801013 http://dx.doi.org/10.1126/sciadv.aau9425 |
_version_ | 1783396663907319808 |
---|---|
author | Abi Habib, Walid Brioude, Frédéric Azzi, Salah Rossignol, Sylvie Linglart, Agnès Sobrier, Marie-Laure Giabicani, Éloïse Steunou, Virginie Harbison, Madeleine D. Le Bouc, Yves Netchine, Irène |
author_facet | Abi Habib, Walid Brioude, Frédéric Azzi, Salah Rossignol, Sylvie Linglart, Agnès Sobrier, Marie-Laure Giabicani, Éloïse Steunou, Virginie Harbison, Madeleine D. Le Bouc, Yves Netchine, Irène |
author_sort | Abi Habib, Walid |
collection | PubMed |
description | Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 down-regulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS. |
format | Online Article Text |
id | pubmed-6382400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63824002019-02-23 Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders Abi Habib, Walid Brioude, Frédéric Azzi, Salah Rossignol, Sylvie Linglart, Agnès Sobrier, Marie-Laure Giabicani, Éloïse Steunou, Virginie Harbison, Madeleine D. Le Bouc, Yves Netchine, Irène Sci Adv Research Articles Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 down-regulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS. American Association for the Advancement of Science 2019-02-20 /pmc/articles/PMC6382400/ /pubmed/30801013 http://dx.doi.org/10.1126/sciadv.aau9425 Text en Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Abi Habib, Walid Brioude, Frédéric Azzi, Salah Rossignol, Sylvie Linglart, Agnès Sobrier, Marie-Laure Giabicani, Éloïse Steunou, Virginie Harbison, Madeleine D. Le Bouc, Yves Netchine, Irène Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders |
title | Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders |
title_full | Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders |
title_fullStr | Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders |
title_full_unstemmed | Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders |
title_short | Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders |
title_sort | transcriptional profiling at the dlk1/meg3 domain explains clinical overlap between imprinting disorders |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382400/ https://www.ncbi.nlm.nih.gov/pubmed/30801013 http://dx.doi.org/10.1126/sciadv.aau9425 |
work_keys_str_mv | AT abihabibwalid transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT brioudefrederic transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT azzisalah transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT rossignolsylvie transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT linglartagnes transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT sobriermarielaure transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT giabicanieloise transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT steunouvirginie transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT harbisonmadeleined transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT leboucyves transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders AT netchineirene transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders |